Lomuscio Sonia, Cocciadiferro Dario, Petrizzelli Francesco, Liorni Niccolò, Mazza Tommaso, Allegorico Annalisa, Ullmann Nicola, Novelli Giuseppe, Cutrera Renato, Novelli Antonio
Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.
Medical Genetics Unit, Tor Vergata University Hospital, 00133 Rome, Italy.
Genes (Basel). 2024 Dec 5;15(12):1573. doi: 10.3390/genes15121573.
: The gene encodes for the catalytic α subunit of Cytoplasmic phenylalanine-tRNA synthetase (FARS1), an essential enzyme for protein biosynthesis in transferring its amino acid component to tRNAs. Biallelic pathogenic variants have been associated with a multisystemic condition, characterized by variable expressivity and incomplete penetrance. Here, we report the case of an 11 year-old girl presenting interstitial lung disease, supratentorial leukoencephalopathy with brain cysts, hepatic dysfunction, hypoalbuminemia, skin and joint hyperlaxity, growth retardation, and dysmorphic features. In addition, our patient also developed two clinical features never reported before: hypergammaglobulinemia and myopic chorioretinitis. : NGS analysis of the patient's skin-derived DNA revealed two novel biallelic variants in gene (NM_004461.3) never described before: the maternal nonsense variant, c.799C>T [p.(Gln267Ter)], and the paternal missense variant, c.737T>C [p.(Met246Thr)], both predicted as deleterious. : From a therapeutic perspective, this young girl has been enrolled in a clinical trial with Nintedanib, in order to treat the severe pulmonary fibrosis, with interesting initial results. : Our findings expand the clinical and molecular spectrum of the -related phenotype and introduce new cues on lung fibrosis treatment in pediatric age.
该基因编码细胞质苯丙氨酸 - tRNA合成酶(FARS1)的催化α亚基,这是一种蛋白质生物合成过程中的关键酶,负责将其氨基酸成分转移到tRNA上。双等位基因致病性变异与一种多系统疾病相关,其特征为表达可变和外显不全。在此,我们报告一名11岁女孩的病例,她表现出间质性肺病、伴有脑囊肿的幕上白质脑病、肝功能障碍、低白蛋白血症、皮肤和关节过度松弛、生长发育迟缓以及畸形特征。此外,我们的患者还出现了两种以前从未报道过的临床特征:高球蛋白血症和近视性脉络膜视网膜炎。对患者皮肤来源的DNA进行的NGS分析揭示了该基因(NM_004461.3)中两个以前从未描述过的新型双等位基因变异:母亲的无义变异,c.799C>T [p.(Gln267Ter)],以及父亲的错义变异,c.737T>C [p.(Met246Thr)],两者均被预测为有害变异。从治疗角度来看,这名年轻女孩已参加了一项使用尼达尼布的临床试验,以治疗严重的肺纤维化,初步结果令人关注。我们的研究结果扩展了与该疾病相关表型的临床和分子谱,并为儿童期肺纤维化治疗提供了新线索。